Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 71335-9670

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 71335-9670). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 01)

Chemical structure of tramadol hydrochloride depicted with labeled molecular components including methoxyphenyl group, hydroxyl group, amine side chain, and hydrochloride salt.*

FDA Label Image

Image-2 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 02)

A concentration-time plot depicting tramadol levels (ng/mL) in blood plasma over 24 hours. Two lines compare Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily versus Tramadol Hydrochloride Tablets 50 mg every 6 hours, illustrating differences in drug concentration profiles over time.*

FDA Label Image

Image-3 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 03)

A line graph comparing M1 metabolite concentration (ng/mL) over time (hours) between Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily and Tramadol Hydrochloride Tablets 50 mg every 6 hours. The graph shows concentration changes over a 24-hour period, with two distinct data lines representing each formulation.*

FDA Label Image

Image-4 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 04)

A line graph presenting data from a study on Tramadol Hydrochloride Extended-Release Tablets showing the percent of patients achieving various levels of pain response threshold improvement. The graph compares four dosages (100 mg, 200 mg, 300 mg, 400 mg) and placebo, with percent improvement from baseline on the x-axis and percent of patients achieving response on the y-axis.*

FDA Label Image

Image-5 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 05)

A line graph showing the percent of patients achieving various levels of response threshold in a study of Tramadol Hydrochloride Extended-Release Tablets for arthritis pain intensity. The x-axis represents response threshold as percent improvement from baseline, and the y-axis shows the percent of patients achieving response. Two lines compare Tramadol Hydrochloride Extended-Release Tablets to placebo, indicating higher response rates for the drug across thresholds.*

FDA Label Image

Label (Lbl713359670)

Label for TRAMADOL HYDROCHLORIDE Extended-Release Tablets USP 300 mg. The label includes the NDC 71335-9670-1 and indicates a package of 30 tablets. It shows the labeler as Bryant Ranch Prepack and the manufacturer as Lupin Limited. Storage instructions specify controlled room temperature.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.